Sunday, October 19, 2008: 6:00 PM
Columbus A-C (Hyatt Regency Penns Landing)
Poster Number Acronyms
COST-EFFECTIVENESS ANALYSIS OF CARDIOPULMONARY RESUSCITATION IN CRITICALLY ILL PATIENTS WITH CANCER
Susannah K. Wallace, MS1, Lincy S. Lal, Pharm.D, PhD1, Lesley-Ann N. Miller-Feher, MS, PhD1 and Scott B. Cantor, PhD2, (1)The University of Texas M. D. Anderson Cancer Center, Houston, TX, (2)The University of Texas M. D. Anderson Cancer Center, Houston, TX TX, USA
COST-EFFECTIVENESS OF ENDOSCOPIC SURVEILLANCE OF PRECANCEROUS GASTRIC LESIONS IN THE UNITED STATES
Jennifer M. Yeh, PhD1, Chin Hur, MD, MPH2, Karen M. Kuntz, ScD3, Majid Ezzati, PhD1 and Sue J. Goldie, MD, MPH1, (1)Harvard School of Public Health, Boston, MA, (2)Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, (3)University of Minnesota School of Public Health, Minneapolis, MN
COST EFFECTIVENESS OF GENETIC TESTING FOR LYNCH SYNDROME AMONG NEWLY DIAGNOSED COLORECTAL CANCER PATIENTS AND THEIR FIRST-DEGREE RELATIVES
Mercy Mvundura, PhD1, Glenn E. Palomaki, BS2, Monica R. McClain, PhD2, Ralph J. Coates, PhD1 and Scott D. Grosse, PhD1, (1)Centers for Disease Control and Prevention, Atlanta, GA, (2)The Warren Alpert Medical School at Brown University, Providence, RI
THE COST-EFFECTIVENESS OF TREATMENTS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AGES 7-10
Eileen A. Sandberg, MS., MBA.1, Kimberly Thompson, ScD1, Lisa Prosser, PhD2, Peter Neumann, ScD3 and Milton C. Weinstein, PhD4, (1)Harvard University, Boston, MA, (2)University of Michigan, Ann Arbor, MI, (3)The Center for the Evaluation of Value and Risk in Health, Boston, MA, (4)Harvard School of Public Health, Boston, MA
COST-EFFECTIVENESS OF SUPPLEMENTATION WITH VITAMIN K FOR THE PRIMARY PREVENTION OF OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN
Olga Gajic-Veljanoski, MD, MSc, University of Toronto, Department of Health Policy, Management and Evaluation, Toronto, ON, Canada, Angela M. Cheung, MD, PhD, FRCP(C), Osteoporosis Program, University Health Network, Toronto, ON, Canada, Kamran Khan, MD, MPH, FRCPC, Centre for Research on Inner City Health, Toronto, ON, Canada, George Tomlinson, PhD, University of Toronto, Department of Health Policy Management and Evaluation, Toronto, ON, Canada and Ahmed M. Bayoumi, MD, MSc, Centre for Research on Inner City Health, the Keenan Research Centre in the Li Ka Shing Knowledge Institute, Toronto, ON ON ON, Canada Canada Canada
COST EFFECTIVENESS OF ROUTINE PULSE OXIMETRY EXAMINATION OF NEWBORNS IN THE UNITED STATES
Scott D. Grosse, PhD, Centers for Disease Control and Prevention, Atlanta, GA, William T. Mahle, MD, Emory University; Children's Healthcare of Atlanta, Atlanta, GA and Robert Koppel, MD, Schneider Children's Hospital, New Hyde Park, NY
SYSTEMATIC REVIEW OF THE COMPARATIVE EFFECTIVENESS OF INHALED CORTICOSTEROIDS FOR THE TREATMENT OF PERSISTENT ASTHMA
Daniel E. Jonas, MD, MPH, Me Bryant Shilliday, PharmD, CDE, CPP, Katie L. Kiser, PharmD, Laura C. Morgan, MA, Patricia Thieda, MA and Dan Reuland, MD, University of North Carolina, Chapel Hill, NC
IN PURSUIT OF THERAPEUTIC PRECISION: HOW OFTEN DO N-OF-1 TRIALS AFFECT TREATMENT DECISIONS?
Nicole B. Gabler, MPH, MHA1, Naihua Duan, PhD2, J. Paul Leigh, PhD1, Sunita Vohra, MD, FRCPC, MSc3 and Richard L. Kravitz, MD, MSPH1, (1)University of California, Davis, Sacramento, CA, (2)The New York Psychiatric Institute of Columbia University, New York, NY, (3)University of Alberta, Edmonton, AB, Canada
COMPARATIVE EFFECTIVENESS OF INHALED CORTICOSTEROIDS AND LEUKOTRIENE MODIFIERS FOR THE TREATMENT OF PERSISTENT ASTHMA IN ADULTS AND CHILDREN: A SYSTEMATIC REVIEW
D.E. Jonas, MD, MPH, Me Bryant Shilliday, PharmD, Katie L. Kiser, PharmD, P. Thieda, MA, L.C. Morgan, MA and D. Reuland, MD, University of North Carolina, Chapel Hill, NC
AGREEMENT OF DECISION ANALYSES AND MATCHING RANDOMIZED CLINICAL TRIALS IN ASSESSMENT OF TREATMENT COMPARISONS: A SYSTEMATIC REVIEW
Rahul S. Mhaskar, MPH1, Ambuj Kumar, MD, MPH2 and Benjamin Djulbegovic, MD, PhD1, (1)H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL, (2)Moffitt Cancer Center, Tampa, FL
A SYSTEMATIC REVIEW: SYNTHETIC AND BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS FOR THE TREATMENT OF PSORIATIC ARTHRITIS
P. Thieda, MA1, D.E. Jonas, MD, MPH1, L.C. Morgan, MA1, K. Donahue, MD, MPH1 and G. Gartlehner, MD, MPH2, (1)University of North Carolina, Chapel Hill, NC, (2)Danube Univ, Vienna, Austria
IMPACT OF LATE-EFFECTS ON THE LIFE EXPECTANCY OF CHILDHOOD CANCER SURVIVORS
Jennifer M. Yeh, PhD1, Larissa Nekhlyudov, MD, MPH2, Sue J. Goldie, MD, MPH1, Ann C. Mertens, PhD3 and Lisa Diller, MD4, (1)Harvard School of Public Health, Boston, MA, (2)Harvard Medical School, Boston, MA, (3)Emory University, Atlanta, GA, (4)Dana-Farber Cancer Institute, Boston, MA
WHY DO PRIMARY CARE PHYSICIANS FAVOR DIFFERENT COLORECTAL CANCER SCREENING STRATEGIES?
James G. Dolan, MD1, Jeroan Allison, MD2, Emily Boohaker, MD2 and Thomas F. Imperiale, MD3, (1)Unity Health System & the University of Rochester, Rochester, NY, (2)University of Alabama at Birmingham, Birmingham, AL, (3)Indiana University School of Medicine, Indianapolis, IN
COMPARATIVE EFFECTIVENESS OF DECISION TREE VERSUS LOGISTIC REGRESSION MODELS IN PREDICTING HIGH HEALTHCARE COSTS
Michael B. Nichol, PhD1, Joanne Wu, MS1, Tara K. Knight, PhD1, Jack Mahoney, MD2 and Christine Berman, PhD2, (1)University of Southern California, Los Angeles, CA, (2)Pitney Bowes, Stamford, CT
COMPARISON OF THREE ALGORITHMS FOR MANAGEMENT OF CHRONIC COUGH IN PEOPLE LIVING WITH HIV IN A LOW-INCOME COUNTRY
Jasmine Nguyen, MD1, Constance Mukabatsinda, MD2, Yerma Coppens, MD2, Anita Asiimwe, MD2, Lutgarde Lynen, MD1 and Jef Van den Ende, PhD1, (1)Institute of Tropical Medicine, Antwerp, Belgium, (2)Centre Hospitalier Universitaire Kigali, Kigali, Rwanda
THE EFFECT OF WEIGHT LOSS ON HEALTH-RELATED QUALITY OF LIFE
Leslee L. Subak, MD1, Angela M. Pinto, MD2, Rena R. Wing, PhD3, Sanae Nakagawa1, Jennifer Creasman, MPH1, John W. Kusek, PhD4, William Herman, MD, MPH5 and Miriam Kuppermann, PhD, MPH6, (1)University of California-San Francisco, San Francisco, CA, (2)Baruch College/CUNY, New York, NY, (3)Brown Medical School, Miriam Hospital, Providence, RI, (4)Nih/niddk, Bethesda, MD, (5)University of Michigan, Ann Arbor, MI, (6)University of California, San Francisco, San Francisco, CA, USA
BORDERLINE AND MILDLY DYSKARYOTIC PAP SMEARS ASSOCIATED WITH ANXIETY AND DISTRESS
Ida J. Korfage, PhD1, Marjolein Van Ballegooijen, MD, PhD1, Johannes A. Huveneers, MSc2 and Marie-Louise Essink-Bot, MD, PhD1, (1)Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, (2)Regional screening organisation in Maastricht (IKL), Maastricht, Netherlands
HEALTH STATUS UTILITIES IN LONG-TERM CARE RESIDENTS IN ONTARIO
Hla-Hla Thein, MD, MPH, PhD1, Tara Gomes, MHSc2, Ba Pham, MSc3, Murray Krahn, MD, MSc3 and Walter Wodchis, PhD3, (1)University of New South Wales, Sydney, Australia, (2)Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care, Toronto, ON, Canada, (3)University of Toronto, Toronto, ON, Canada
A MULTIFACETED LONGITUDINAL COMPARATIVE ASSESSMENT OF EVIDENCE-BASED MEDICINE SKILLS
Alan Schwartz, PhD1, Jordan Hupert, MD1, Carol Scherrer, MALS1, Leo G. Niederman, MD1, Karen Connell, MS1 and Josephine Dorsch, MALS2, (1)University of Illinois at Chicago, Chicago, IL, (2)University of Illinois at Chicago, Peoria, IL
TUTORING CHEST PAIN DIAGNOSIS: RELATIVE CONTRIBUTION OF CASES, CONTRASTS, AND PROTOTYPES
Robert M. Hamm, PhD1, Frank J. Papa, DO, PhD2 and David G. Aldrich, BS2, (1)University of Oklahoma Health Sciences Center, Oklahoma City, OK, (2)Texas College of Osteopathic Medicine, Fort Worth, TX
PATIENT-PROVIDER COMMUNICATION OF SCIENTIFIC UNCERTAINTY AND SURGICAL DECISION MAKING
Mary C. Politi, PhD, Miriam Hospital/Alpert Medical School of Brown University, Providence, RI, Melissa A. Clark, PhD, Brown University, Providence, RI, Glyn Elwyn, PhD, Cardiff University, Cardiff, United Kingdom and Don Dizon, MD, FACP, Alpert Medical School of Brown University, Providence, RI
THE COST-EFFECTIVENESS OF AN RCT TO ESTABLISH WHETHER 5 OR 10 YEARS OF BISPHOSPHONATE TREATMENT IS THE BETTER DURATION FOR WOMEN WITH A PRIOR FRACTURE
Matt Stevenson, PhD1, Jeremy E. Oakley, PhD2, Myfanwy Lloyd Jones, PhD1, Alan Brennan, BSc, MSc3, Juliet E. Compston4, Eugene V. McCloskey3 and Peter L. Selby5, (1)The School of Health and Related Research, University of Sheffield., Sheffield, England, (2)University of Sheffield, Sheffield, England, (3)University of Sheffield, Sheffield, United Kingdom, (4)University of Cambridge, School of Clinical Medicine and Addenbrooke's NHS Trust, Cambridge, United Kingdom, (5)Manchester Royal Infirmary, Manchester, United Kingdom
PREDICTING THE RISK OF INVASIVE VERSUS INSITU BREAST CANCER FOR CLINICAL MANAGEMENT
Jagpreet Chhatwal, MS1, Oguzhan Alagoz, PhD1, Houssam Nassif1, Edward A. Sickles, MD2, Christopher Jovais2 and Elizabeth S. Burnside, MD, MPH, MS1, (1)University of Wisconsin, Madison, WI, (2)University of California, San Francisco, CA
BIOPSY OR SHORT INTERVAL FOLLOW-UP? A MARKOV DECISION PROCESS MODEL FOR EARLY DIAGNOSIS OF BREAST CANCER
Jagpreet Chhatwal, MS1, Oguzhan Alagoz, PhD2 and Elizabeth S. Burnside, MD, MPH, MS1, (1)University of Wisconsin, Madison, WI, (2)University of Wisconsin, Madison, USA
COMPARING ARTIFICIAL NEURAL NETWORK TRAINING STRATEGIES FOR BREAST CANCER RISK PREDICTION
Turgay Ayer1, Oguzhan Alagoz, PhD1, Jagpreet Chhatwal, MS1, Jude W. Shavlik1, Charles E. Kahn, Jr., MD, MS2 and Elizabeth S. Burnside, MD, MPH, MS1, (1)University of Wisconsin, Madison, WI, (2)Medical College of Wisconsin, Milwaukee, WI
A MICROSIMULTION MODEL FOR ESTIMATING THE LIFETIME DIRECT MEDICAL COSTS OF HIV IN BRITISH COLUMBIA
Karissa M. Johnston, MSc1, Adrian Levy, PhD2, Andrew H. Briggs, DPhil3, Robert Hogg, PhD4, Pal Gustafson, PhD2, Mark Tyndall, ScD, MD4 and Julio Montaner, MD4, (1)University of British Colulmbia, Vancouver, BC, Canada, (2)University of British Columbia, Vancouver, BC, Canada, (3)University of Glasgow, Glasgow, United Kingdom, (4)Centre for Excellence in HIV/AIDS Research, Vancouver, BC, Canada
EVALUATING THE IMPACT OF ADHERENCE TO DETERMINE THE OPTIMAL START TIME FOR STATINS FOR DIABETES PATIENTS
Jennifer E. Mason, BS1, Nilay D. Shah, PhD2, Brian T. Denton, PhD1, Murat Kurt, MS3, Jason Egginton, MPH2 and Steven Smith, MD4, (1)North Carolina State University, Raleigh, NC, (2)Mayo Clinic, Rochester, MN, (3)University of Pisttsburgh, Pittsburgh, PA, (4)Mayo Clinic College of Medicine, Rochester, MN
DEVELOPMENT OF AN OPTIMAL POLICY FOR STATIN INITIATION AMONG TYPE 2 DIABETES PATIENTS
Murat Kurt, MS1, Brian T. Denton, PhD2, Andrew J. Schaefer, PhD1, Nilay D. Shah, PhD3 and Steven Smith, MD4, (1)University of Pittsburgh, Pittsburgh, PA, (2)North Carolina State University, Raleigh, NC, (3)Mayo Clinic, Rochester, MN, (4)Mayo Clinic College of Medicine, Rochester, MN
COMPLEX DETERMINANTS OF THE LEAST COSTLY WAY TO DESIGN A STUDY TO DETECT DIFFERENCES IN QALYS WITH A GIVEN POWER
Kevin D. Frick, PhD1, Lynn Huynh, MBA, MPH1 and Melissa A. Clark, PhD2, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Brown University, Providence, RI
![[ Visit Client Website ]](images/banner.gif)